← feed

Is NCT03325595 results overdue?

Yes — results are overdue. Primary completion was 2018-02-26; the FDAAA-801 reporting deadline (2019-02-26) passed 2718 days ago and no results are posted on ClinicalTrials.gov.

Single Ascending Dose to Study the Safety, Tolerability, PK and PD Effects of AEF0117

NCT IDNCT03325595 ↗
SponsorAelis Farma (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2018-02-26 (ACTUAL)
Reporting deadline2019-02-26 (completion + 365d)
Days overdue2718
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 3dccb720483fa1d5… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03325595. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →